AllPennyStocks.com LLY Stock In Spotlight After Study Shows Zepbound Use Linked To Up To 38% Lower Healthcare Costs In Adults Above 55 Years
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

LLY Stock In Spotlight After Study Shows Zepbound Use Linked To Up To 38% Lower Healthcare Costs In Adults Above 55 Years

Researchers used two analytical methods, both of which showed that monthly healthcare costs fell over time, but neither included the cost of Zepbound.

Other Penny Stock Movers

Counter-Drone Systems Developer Gains 32% as First U.S. Federal Order Lands
Washington Is Financing Critical-Mineral Projects. What Will Canada Do?
Natural Hydrogen Explorer Jumps 11% on Record Gas Read
Most Popular
{{ index + 1 }}


Back to Top